US FDA revokes emergency use authorization for J&J’s COVID vaccine

The Cheap InvestorJune 1, 2023June 1, 202301 mins

(Reuters) – The U.S. Food and Drug Administration said on Thursday it has revoked the emergency use authorization for Johnson & Johnson’s COVID-19 vaccine.

(Reporting by Bhanvi Satija in Bengaluru)

Related News

Mastercard profit beats estimates on steady transaction volumes

April 30, 2026

Walmart opens third U.S. milk processing facility with $350 million investment

April 29, 2026

EU prepares to clash with US again over shipping carbon levy

April 24, 2026

American Airlines rejects United merger, explores deeper Alaska ties

April 23, 2026

Sign up for our free The Cheap Investor Newsletter!

Discover new market trends and ideas directly to your inbox.

✅ You're in! Check your inbox soon.

By submitting your email address, you'll receive a free subscription to The Cheap Investor newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.